A private financing round with funds launched as part of Alvotech’s proposed merger with a special purpose acquisition company has oversubscribed by $21m, driven by increased interest from investors in the biosimilar firm’s native Iceland.
As a result, Alvotech now anticipates raising at least $175m from the private investment in public equity financing round being...